Companies
AbbVie
PharmaceuticalsNorth Chicago, IllinoisABBVAbout 57,000 employees
More about AbbVie
Drugmaker that develops and sells medicines in immunology, neuroscience and oncology, plus Allergan aesthetics products such as Botox
Revenue
$61.2B
Fiscal 2025, up about 9%
Employees
About 57,000
As of December 2025
Stock
ABBV
New York Stock Exchange
Headquarters
North Chicago, Illinois
CEO
Robert Michael
Since July 2024
BrandsSkyrizi, Rinvoq, Humira, Vraylar, Botox
Current strategyGrowing newer immunology drugs as Humira faces biosimilars and adding to its pipeline, including the proposed Apogee Therapeutics acquisition announced in July 2026
Recent workforce changes85 roles cut in Irvine, California in July 2026 and 59 in the Bay Area in January 2026 (WARN notices)
CompetitorsJohnson & Johnson, Eli Lilly, Bristol Myers Squibb
Related companiesJohnson & JohnsonEli LillyBristol Myers Squibb
Checked October 11, 2026 · Sources: sec.gov, sec.gov (2), warntracker.com, warntracker.com (2)
Be the first to post about AbbVie
No one has started a discussion here yet. Yours is anonymous and appears right away, and we don’t store who wrote it.
Or follow AbbVie to see the first post in your watchlist.
Follow AbbVie in a feed reader, no account needed: RSS feed